- Cancer PHGKB -
Last Posted: Feb 02, 2018
- Communication of cancer-related genetic and genomic information: A landscape analysis of reviews.
Peterson Emily B et al. Translational behavioral medicine 2018 Jan (1) 59-70
- Inheritance Matters: The Race to Prevent New Ovarian Cancer Cases
SC. Modesitt, Onc Live, Feb 1, 2018
- Liquid Biopsy in Prostate Cancer: A Case for Comprehensive Genomic Characterization of Circulating Tumor Cells.
Boral Debasish et al. Clinical chemistry 2018 Feb (2) 251-253
- NCI Recognizes World Cancer Day 2018
- A prognostic mutation panel for predicting cancer recurrence in stages II and III colorectal cancer.
Sho Shonan et al. Journal of surgical oncology 2017 Dec 116(8) 996-1004
- Breast Cancer Screening in Women at Higher-Than-Average Risk: Recommendations From the ACR.
Monticciolo Debra L et al. Journal of the American College of Radiology : JACR 2018 Jan
- Development and Clinical Validation of a Blood Test Based on 29-Gene Expression for Early Detection of Colorectal Cancer.
Ciarloni Laura et al. Clinical cancer research : an official journal of the American Association for Cancer Research 2016 Sep 22(18) 4604-11
- Do Genomic Assays Provide the Necessary Confidence to De-escalate Adjuvant Therapy?
Costa Ricardo L B et al. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 2018 Jan JCO2017769802
- FDA Benefit-Risk Assessment of Osimertinib for the Treatment of Metastatic Non-Small Cell Lung Cancer Harboring Epidermal Growth Factor Receptor T790M Mutation
Odogwu Lauretta et al. The oncologist 2017 Dec
- Genetic assessment wait time indicators in the High Risk Ontario Breast Screening Program.
Eisen Andrea et al. Molecular genetics & genomic medicine 2018 Jan
No hay comentarios:
Publicar un comentario